:::

詳目顯示

回上一頁
題名:慢性C型肝炎患者接受干擾素合併Ribavirin治療的決策過程
書刊名:長庚護理
作者:張淑娟陳淑雯 引用關係陳淑貞陳筱瑀 引用關係楊勝舜
作者(外文):Chang, Shu-chuanChen, Shu-wenChen, Shu-jenChen, Hsiao-yuYang, Sheng-shun
出版日期:2007
卷期:18:1=57
頁次:頁21-31
主題關鍵詞:C型肝炎干擾素合併ribavirin治療決策過程現象學研究Hepatitis CInterferon plus ribavirin therapyDecision-making processPhenomenological research
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(1) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:7
  • 點閱點閱:38
期刊論文
1.黎小娟、李從業(19980600)。母血篩檢唐氏症陽性反應的孕婦面對羊膜穿刺之決策經驗。護理雜誌,45(3),51-64。new window  延伸查詢new window
2.Matteson, P.、Hawkins, J. W.(1990)。Concept analysis of decision making。Nurs Forum,25,4-10。  new window
3.Wright, I. A.(2000)。Monitoring depression in patients undergoing alpha-interferon and ribavirin for hepatitis C。Gastroenterology Nursing,23(6),275-280。  new window
4.Glacken, M., Coates, V., Kernohan, G.,、Hegarty, J.(2003)。The experience of fatigue for people living with hepatitis C。Journal of Clinical Nursing,12(2),244-253。  new window
5.Bayliss, M. S.、Ware, J. E. Jr.、Gandek, B.、Bungay, K. M.、Sugano, D.、Hsu, M. A.(1998)。A questionnaire to assess the generic and disease- specific health outcomes of patients with chronic hepatitis C。Quality of Life Reasearch,7(1),39-55。  new window
6.Kahn, D. L.(1993)。Ways of discussing validity in qualitative nursing research。Western Journal of Nursing Research,15(1),122-126。  new window
7.Heitkemper, M., Jarrett, M., Kurashige, E. M.,、Carithers, R.(2000)。Chronic Hepatitis C implications for health-related quality of life。Gastroenterology Nursing,24(4),170-177。  new window
8.許景盛、高嘉宏(20050300)。C型肝炎治療的新進展--干擾素相關治療的影響因素和因應策略。當代醫學,32(3)=377,218-231。  延伸查詢new window
9.梁程超、高嘉宏(20030400)。2002年C型肝炎治療共識簡介。當代醫學,30(4)=354,314-319。  延伸查詢new window
10.劉俊人、賴明陽(19981100)。慢性C型肝炎之治療。臺灣醫學,2(6),661-667。  延伸查詢new window
11.賴明陽(20030200)。C型肝炎治療的最新進展。臨床醫學,51(2)=302,96-100。new window  延伸查詢new window
12.吳淑美、余玉眉、黃思誠、楊承芳(2003)。婦女對子宮全切除術之決策型態探討。台灣醫學,8(32),32-41。  延伸查詢new window
13.周雪棻、李從業(2005)。接受輸卵管結紮婦女的決策過程。實證護理,1(1),6-11。new window  延伸查詢new window
14.黎小娟、陳玉玲(2002)。以RU486施行人工流產的已婚婦女之決策過程。長庚護理,13(2),136-145。new window  延伸查詢new window
15.賴世偉、黃金財、李佳霙(2004)。健檢民眾B型及C型肝炎盛行率之描述性分析:以某醫學中心為例。中台灣醫誌,9(Suppl1),64-69。  延伸查詢new window
16.Bernstein, D., Kleinman, L., Barker, C.M., Revicki, D.M.,、Green, J.(2002)。Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients。Hepatology,35(3),704-708。  new window
17.Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L. Jr., et al.(2002)。Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection。The New England Journal of Medicine,347(13),975-982。  new window
18.Hassanein T., Cooksley G., Sulkowski M., Smith C., Marinos G., Lai MY., et al.(2004)。The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C。Journal of Hepatology,40(4),675-681。  new window
19.Heaney C. A.,、Hall J. A.(1997)。Patient-provider communication。Health behavior and health education (2nd ed.),206-226。  new window
20.Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., et al.(1990)。Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis of detection of antibody to hepatitis C virus。Hepatology,12(4),671-675。  new window
21.McHutchison, J. G., Ware, J. E. Jr., Bayliss, M. S., Pianko, S., Albrecht, J. K., Cort, S., et al.(2001)。The effects of interferon Alpha-2b in combination with ribavirin on health related quality of life and work productivity。Journal of Hepatology,34(1),140-147。  new window
22.Pierce F.、Hicks F.(2001)。Patient decision- making behavior。Nursing Research,50(5),267-274。  new window
23.Seeff, L. B.(1997)。Natural history of hepatitis C。Hepatology,26(Suppl 1),21-28。  new window
24.Tiffen, L.,、Sheridan, S.(2002)。Improving take-up of hepatitis C services。Nursing Time,98(43),30-32。  new window
25.Ware, J. E. Jr., Bayliss, S., Mannocchia, M.,、Davis, G. L.(1999)。Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response。Hepatology,29 (Suppi. 6),,3S-6S。  new window
26.World Health Organization(1997)。WHO Weekly Epidemiological Record74(46),341-349。  new window
27.Yu, M. L., Dai, C. Y., Lin, Z. Y., Lee, L. P., Hou, N. J., Hsieh, M.Y., et al.(2006)。A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus nbavirin for genotype- lb-infected chronic hepatitis C patients: a pilot study in Taiwan。Liver International,26(1),73-81。  new window
28.Zucker, D.M.,、Miller, B.W.(2001)。Assessment of side effects in patients with chronic hepatitis C receiving combination therapy。Gastroenterology Nursing,24(4),192-196。  new window
學位論文
1.趙美珍(2004)。肝硬化病患疲倦與睡眠品質之相關因素探討(碩士論文)。臺北醫學大學。  延伸查詢new window
2.鐘孟雄(2003)。六週次運動訓練對B型肝炎學生肝功能及疲勞度之影響,臺北。  延伸查詢new window
3.傅淑瑩(1999)。慢性病毒性肝炎患者接受干擾素治療期間之疲倦感與自我照顧行為的探討,高雄。  延伸查詢new window
圖書
1.Orem, D. E.(2001)。Nursing: Concepts of practice (6th ed.)。Thousand Oaks, CA:Mosby。  new window
2.Giorgi, A.(1988)。Phenomenology and psychological research。Pittsburgh, PA:Duquesnw University Press。  new window
3.游伯龍(198712)。行為的新境界--理論與運用。台北:聯經出版公司。  延伸查詢new window
4.Lincoln, Yvonna S.、Guba, Egon G.(1985)。Naturalistic Inquiry。Sage。  new window
5.行政院衛生署(2003)。台灣十大死亡原因統計。台北:行政院衛生署。  延伸查詢new window
6.Heaney, C. A.、Hall, J. A.(1997)。Patient - provider communication。Health behavior and health education (2nd ed.)。San Francisco:Jossey-Bass。  new window
其他
1.中央健康保險局(2003)。全民健康保險藥品給付規定全民健康保險藥品給付規定全民健康保險加強慢性C型肝炎治療試辦計畫公告。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top